Take your place in the future of PCD
Take your place in the future of PCD
R E C O D E
It’s estimated that around one in 10,000
people has PCD, with approximately
46,000 undiagnosed in the US.
PCD is a rare genetic disorder that affects the cilia, the tiny hair-like structures on the surface of cells that line the upper and lower airways. Symptoms of PCD are:
A persistent cough
Recurrent ear infections
Family history of PCD
And more...
Contact us
Sano Customer Support
TEL: +1208-276-9155
© Recode Therapeutics, Inc. 2023. All rights reserved
I’m a healthcare provider
Find out if my patient is eligible for genetic testing for PCDI’m a patient interested in participating
Find out if I'm eligible for genetic testing for PCDContact us
Sano Customer Support
TEL: +1208-276-9155
© Recode Therapeutics, Inc. 2023. All rights reserved
L E A R N M O R E
Could you have Primary Ciliary Dyskinesia?
PCD is a rare genetic disorder that leads to chronic respiratory infections. ReCode is developing a new treatment for PCD caused by mutations in the DNAI1 gene, an essential gene for ciliary movement. If you have experienced symptoms of PCD, such as chronic respiratory infections starting when you were a child, we strongly encourage you to participate.
